Lupin named amongst AON Best Employers India 2016


Mumbai, April 05, 2016: Pharma Major Lupin Limited (Lupin) announced today that it was recognized as AON Best Employers India 2016. Lupin is the only pharmaceutical company on the list this year and part of 25 organizations to feature on the list.

Commenting on the recognition, Mr. Nilesh Gupta, Managing Director, Lupin Limited said “We are very pleased to be included in the AON Best Employers India 2016 list. It is recognition of our employee centricity which goes well beyond traditional employee engagement programs. We have not only focused on nurturing talent and leadership but have developed platforms that facilitate collaboration, knowledge-sharing and creating institutional value; at Lupin we believe in building a culture where entrepreneurship and innovation thrive.”

“We congratulate Lupin on being adjudged an Aon Best Employer. Lupin's focus on building talent for employability positions it uniquely to be a winning workplace. Such practices have extended beyond in-house talent development through Leader Plus and Top 100 like programs, to Learn & Earn program which builds employability in the community Lupin operates in.” added Tarandeep Singh, Partner, Talent & Performance Consulting, Aon Hewitt (India).


About the Aon Best Employers Study
The Aon Best Employers program is a global study that was first conducted in 2001. In Asia, it is run in 12 markets: China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Singapore, Taiwan, Thailand, Australia and New Zealand. Participation in the program helps define what makes a winning workplace.

The Aon Best Employers India 2016 Study, in partnership with BW Businessworld and Bloomberg TV India, covered 113 companies across 12 industries, cumulatively employing approximately 950,000 employees.

A rigorous analysis is run to measure the alignment between “Intent-Design-Experience”, assessed through CEO survey and interview, people practices survey and employee opinion survey for all participating organizations. A shortlisted set is taken through an intense on-site audit to validate the details provided. Client names are masked during this process, and revealed to the jury only post final selection. An external panel of unbiased jury comprising corporate and academic community evaluated the participants and arrived at the final list of India’s 25 Best Employers of 2016.


About Lupin Limited
Headquartered in Mumbai, Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership positions in the Anti-TB and Cephalosporin segment.

Lupin is the 6th largest and fastest growing top 10 generics player in the US (5.5% market share by prescriptions, IMS Health) and the 3rd largest Indian pharmaceutical company by sales globally. The Company is also the fastest growing top 10 generic pharmaceutical players in Japan (ranked 9th) and South Africa (ranked 4th – IMS Health).

For the financial year ended 31st March 2015, Lupin's Consolidated turnover and Profit after Tax were Rs. 125,997 million (USD 2.06 billion) and Rs. 24,032 million (USD 393 million) respectively.

About Lupin Pharmaceuticals Inc. (LPI)
Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, affordable generic medicines and branded formulations trusted by healthcare professionals and patients across geographies.

Please visithttp://www.lupin.com for more information.
You could also follow us on Twitter - www.twitter.com/lupinlimited
For more information on LPI, please visit http://www.lupinpharmaceuticals.com.
CIN: L24100MH1983PLC029442 Registered Office: 159, C.S.T. Road, Kalina, Santacruz (East), Mumbai - 400 098


For more information, please contact –


Shamsher Gorawara
Head - Corporate Communications
Ph: +91-22- 98 20 338 555
Email: shamshergorawara@lupin.com


Alpesh Dalal
Head - M & A and Investor Relations
Lupin Limited
Ph: +91 98 20 023 511
Email: alpeshdalal@lupin.com


Safe Harbor Statement